<DOC>
	<DOCNO>NCT00619164</DOCNO>
	<brief_summary>The purpose study assess safety tolerability E5555 Japanese patient acute coronary syndrome .</brief_summary>
	<brief_title>A Double-Blind Study E5555 Japanese Patients With Acute Coronary Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Platelet Aggregation Inhibitors</mesh_term>
	<criteria>1 . 45 80 year old ( time inform consent ) 2 . Male female ( female childbearing potential must contracepted ) 3 . Confirmed acute coronary syndrome 1 . Unwilling unable provide inform consent 2 . History acquire congenital bleeding disorder , coagulopathy , platelet disorder 3 . Recent trauma major surgery 4 . Evidence active pathological bleeding screen history gastrointestinal genitourinary bleed unknown cause within 24 week prior screen 5 . History intracranial bleed history hemorrhagic retinopathy 6 . History New York Heart Association ( NYHA ) class III IV congestive heart failure 7 . Pregnant lactating woman</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>Platelet Aggregation Inhibitors</keyword>
	<keyword>Coronary Stenosis</keyword>
	<keyword>Coronary Thrombosis</keyword>
</DOC>